Neuropsychiatric biomarker discovery: go big or go home.

Trends Mol Med

Institute of Developmental and Regenerative Medicine, Department of Paediatrics, University of Oxford, Oxford, OX3 7TY, UK; Department of Psychiatry and Behavioral Sciences, UCSF Weill Institute for Neurosciences, University of California, San Francisco, CA 94158, USA. Electronic address:

Published: November 2023

Technological advances have enabled high-throughput omics assays, such as parallelized screening of lipids across plasma samples. Pioneering a new paradigm for neuropsychiatric biomarker discovery, Yap et al. describe a large-scale systematic analysis of comprehensive phenotypic, genotypic, environmental, and lipidomic data to unravel the intricate interplay between these and autism-associated traits.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10879988PMC
http://dx.doi.org/10.1016/j.molmed.2023.09.002DOI Listing

Publication Analysis

Top Keywords

neuropsychiatric biomarker
8
biomarker discovery
8
discovery big
4
big technological
4
technological advances
4
advances enabled
4
enabled high-throughput
4
high-throughput omics
4
omics assays
4
assays parallelized
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!